UNSPSC 51162343: Belladonna/chlorpheniramine/ephedrine/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162343 Belladonna/chlorpheniramine/ephedrine/phenobarbital is a Commodity code under which state and local governments procure pharmaceutical and medical products—specifically parenteral nutrition solutions, intravenous fluids, naloxone, and drug deactivation systems—to support correctional health care, emergency medical response, and community health initiatives. The Washington State Department of Corrections and Seminole County, Florida have solicited supplies under this code within the past four months, with purchases ranging from routine parenteral nutrition delivery to opioid-reversal and harm-reduction equipment. State correctional departments and county health and public-safety agencies appear to be the primary issuing bodies. The Washington DOC procurement emphasizes rapid delivery (24-hour turnaround for parenteral nutrition, 8-hour for other parenteral products) and requires bidders to hold state business licensure, pass NCIC clearance, and maintain multiple insurance policies including Commercial General Liability, Professional Liability, Business Automobile Liability, and Cyber Liability coverage.

Activity under the code is concentrated in Washington and Florida, based on recent solicitations. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026 with a response deadline of October 7, 2026 at 4:00 PM PST, seeking parenteral products and services for eight facilities across three regions with potential awards to up to three bidders per region and an initial contract term through June 30, 2030. The procurement includes set-aside aspirations for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), and requires a Subcontractor Inclusion Plan. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; that solicitation has already closed. The Washington opportunity remains active and represents the most current pursuit under the code for state and local buyers.